INTRODUCTION
Bcl-2 family proteins are key regulators of apoptosis (programmed cell death) (for recent reviews see [1, 2] ). Protein-protein interactions are central to the function and regulation of these proteins and Bcl-2 forms homodimers and heterodimers with related family members, such as Bax. Bcl-2 has also been shown to interact with several non-family-member proteins, including NIP1, NIP2, NIP3, p53 BP2, Raf-1, CED-4, calcineurin, R-Ras and Bag-1 [1, 2] .
Murine Bag-1 contains 219 amino acid residues and has an apparent molecular mass of 29 kDa [3] . Although Bag-1 overexpression alone has little affect on rates of apoptosis of Jurkat T-cells, Bag-1 co-operates with Bcl-2 to suppress Fas-mediated and staurosporine-induced and cytotoxic T-lymphocyte-induced apoptosis [3] . More recently, Bag-1, like Bcl-2, has been demonstrated to interact with the Raf-1 serine\threonine kinase, although neither Bag-1 nor Bcl-2 is phosphorylated by Raf-1 [4, 5] . In addition, Bag-1 has been identified as a hepatocyte growth factor (HGF) and platelet-derived growth factor (PDGF) receptor binding protein, and Bag-1 enhances suppression of apoptosis by HGF or PDGF [6] . Thus, Bag-1 interacts with multiple cellular targets and suppresses apoptosis in several systems.
Recently, Takayama et al. [7] reported the isolation and sequence of a human Bag-1 cDNA and identified a human Bag-1 protein with a molecular mass of 34 kDa. The human Bag-1 cDNA is essentially identical with the previously reported RAP46 cDNA, which was identified in a screen for proteins that Abbreviations used : DTT, dithiothreitol ; FCS, fetal calf serum ; GST, glutathione S-transferase ; HGF, hepatocyte growth factor ; NLS, nuclear localization signal ; ORF, open reading frame ; PDGF, platelet-derived growth factor ; RACE, rapid amplification of cDNA ends ; RPA, RNase protection assay ; SV40, simian virus 40. 1 To whom correspondence should be addressed mouse Bag-1 cDNA is partial, and sequencing of additional murine Bag-1 RNA 5h sequences demonstrated that human and murine Bag-1 cDNAs contain longer open reading frames than originally suspected. We determined which open reading frames gave rise to the Bag-1 isoforms in human cells. Suprisingly, translation of neither protein initiated at the first in-frame methionine, and cells do not express Bag-1\RAP46 proteins with the previously proposed structures ; p50 Bag-1 initiates at an upstream CUG codon, whereas p36 Bag-1 initiates at a downstream AUG codon. Therefore, cells express two differently localized Bag-1 isoforms generated by alternative translation initiation, and Bag-1 proteins may play a dual role in regulating apoptosis and steroid hormone-dependent transcription.
interacted with the activated glucocorticoid receptor, and RAP46 protein was subsequently shown to interact with several activated steroid hormone receptors [8] . The Bag-1\RAP46 cDNA has been proposed to contain a 274 amino acid open reading frame (ORF), beginning at the first in-frame methionine, that gives rise to human Bag-1\RAP46 proteins [7, 8] ; the 34 kDa human Bag-1 protein is therefore reported to contain an N-terminal extension of 55 amino acids relative to the murine protein [7] . However, there is considerable confusion and conflicting evidence regarding the relationship of this proposed ORF to Bag-1 proteins. Takayama et. al. [7] reported that, in itro, the product obtained of the proposed ORF has a molecular mass of 34 kDa (Bag-1), whereas Zeiner and Gehring [8] reported a major product of 46 kDa (RAP46). More importantly, the relationship between the ' in itro ' products of the RAP46\Bag-1 cDNA and endogenous Bag-1 proteins has not been examined in detail.
In the present paper we have characterized Bag-1 RNA and protein expression in mammalian cells and resolved these issues. In addition to the 32 kDa and 36 kDa Bag-1 isoforms previously identified in murine and human cells respectively, cells express a 50 kDa Bag-1 isoform. In murine myeloid cells, Bag-1 isoforms have distinct subcellular localizations, suggesting that they are functionally distinct. Finally, we demonstrate that cells do not express proteins with the structures previously assigned to either Bag-1 or RAP46 [7, 8] ; p50 Bag-1 translation initiates at a CUG codon upstream of the first in-frame methionine and p36 Bag-1 translation initiates at a downstream AUG codon. Thus, cells express two differently localized Bag-1 isoforms generated by alternative translation intiation. WEHI-3 and NFS-56 murine myeloid cell lines, WEHI-22  and WEHI-279 murine T-cell lines and WEHI-231, NFS-70 and  NFS-112 murine B-cell lines were maintained in RPMI-1640 medium supplemented with 10 % (v\v) fetal calf serum (FCS) [9, 10] . The medium for WEHI-231 cells was additionally supplemented with 0.05 mM 2-mercaptoethanol. These cell lines were kindly provided by Dr. J. N. Ihle 
MATERIALS AND METHODS

Cell culture
Generation of anti-Bag-1 antibody
The murine Bag-1 coding sequence [3] was amplified by PCR using primers CGC GGA TCC ATG GCC AAG ACC GAG GAG AT and AAG GAA TTC TTC AGC CAG GGC CAA GTT TG and cDNA was generated using total RNA prepared from mouse liver. The PCR product was digested with BamHI and EcoRI and cloned into plasmid GEX2TK (Pharmacia) which had been digested with the same restriction enzymes to give GEX-mBag-1. GEX2TK or GEX-mBag-1 plasmids were transformed into BL21 bacteria and glutathione S-transferase (GST) non-fusion and GST-mBag-1 proteins respectively, induced with 0.3 mM isopropyl β--thiogalactosidase for 2 h and purified using glutathione-Sepharose-4B beads (Pharmacia), as previously described [11] . Three rabbits were repeatedly immunized with GST-mBag-1 and screened for reactivity against the 32 kDa Bag-1 protein in murine cells by Western blotting. All three rabbits responded to immunization and large-scale bleeds were taken from the rabbit that displayed the best reactivity.
Western and Northern blotting
For Western blotting (immunoblotting), cells were collected by centrifugation and resuspended in RIPA [0.15 M NaCl, 1 % (v\v) Nonidet P40, 0.5 % (v\v) sodium deoxycholate, 0.1 % (w\v) SDS, 50 mM Tris\HCl (pH 8.0) and protease inhibitors]. After 5 min on ice, the lysates were clarified by centrifugation and supernatants were collected. The protein concentration of a sample of the lysate was determined using the Bio-Rad assay with BSA as a standard. The remaining lysate was diluted with an equal volume of 2i protein sample buffer [100 mM Tris\HCl (pH 6.8)\4 % (w\v) SDS\0.2 % (w\v) Bromophenol Blue\20 % (v\v) glycerol\200 mM dithiothreitol (DTT)] and proteins were denatured by heating at 95 mC for 5 min. Equivalent amounts of cell lysates were resolved on SDS polyacrylamide gels and electrophoretically transferred to nitrocellulose. The filter was incubated in blocking buffer [5 % (w\v) dried non-fat milk in PBS] to block non-specific protein-binding sites, and antibody incubations were in binding buffer [5 % (w\v) dried non-fat milk in 150 mM NaCl\10 mM Tris\HCl, pH 8.0 (TS buffer)]. After each antibody incubation, the filters were washed twice in TS buffer and twice in TST buffer [TS buffer supplemented with 0.05 % (v\v) Tween]. Bound immunocomplexes were detected by enhanced chemiluminescence (ECL ; Amersham) and luminography.
Anti-Bag-1 was used at a 1 : 2000 dilution and the rabbit antiBag-1 antibody C-16 (Santa Cruz Biotechnology, Inc.) was used at a concentration of 0.5 µg\ml. The mouse Bcl-2-specific hamster monoclonal antibody 3F11 (Pharmingen) was used at a concentration of 5 µg\ml, followed by a rabbit anti-hamster IgG antibody (Sigma) at a concentration of 1 µg\ml. The human Bcl-2-specific mouse monoclonal antibody C124 (Dako) was used at a final concentration of 1 µg\ml. The F " -β-ATPase-specific rabbit antibody was a gift from Dr W. Neupert (Ludwig-MaximiliansUniversita$ t, Munich, Germany). The final antibodies were horseradish peroxidase-conjugated donkey-(anti-rabbit) Ig or sheep-(anti-mouse) Ig (both Amersham) and were used at a dilution of 1 : 5000 to 1 : 10 000.
Isolation of total RNA and Northern hybridization were performed as previously described [12] . The murine Bag-1 probe was the BamHI-EcoRI insert from GEX-mBag-1.
5h Rapid amplification of cDNA ends (RACE)
Poly(A) + RNA was isolated from murine myeloid BXH2-4S cells using oligo(dT) cellulose and 5h RACE was performed using the 5h\3h RACE kit (Boehringer Mannheim) according to the manufacturer's instructions. Briefly, RNA was converted into cDNA using the Bag-1-specific primer S8951 (ACGCGTCGACCATC-TCCTCGGTCTTGG), tailed with terminal transferase and dATP, and products were amplified using Pfu DNA polymerase (Stratagene) and oligo(dT) anchor primer [GAC CAG GCG TAT CGA TGT CGA C(T)
"' ] and Bag-1 primer T1114 (ACG-CGTCCCTCGGTTTGGGTCGCC). The PCR products were digested with SalI and cloned into pBluescript KS(k) (Stratagene) that had been digested with SalI and EcoRV. The sequence of the cloned inserts was determined by double-stranded sequencing (Sequenase version 2.0 ; U.S. Biochemical Inc.). Sequencing was performed on both strands and using multiple RACE clones, except for the 5h 80 nts which were present in a single clone (plasmid RACE.3). The novel mouse Bag-1 RNA sequence appears in the GenBank Nucleotide Sequence Database under accession number AFO19889.
RNase protection assay (RPA)
Plasmid RACE.3 was digested with SalI and the riboprobe generated using T7 RNA polymerase. RPA was performed using total RNA from M1 cells (10 µg), or yeast RNA (10 µg) as a control, and the RPA II kit (Ambion) according to the manufacturer's instructions. Briefly, RNA was precipitated with gelpurified riboprobe (50i10$ C B herenkov c.p.m.), resuspended in hybridization solution (20 µl) and incubated overnight at 42 mC. Unprotected probe was removed by digestion using RNase A\T1 and protected fragments were resolved on a denaturing polyacrylamide gel.
Cloning of Bag-1/RAP46 cDNA 5h truncations and point mutants and in vitro translation
Plasmids for in itro translation of different regions of the Bag-1\RAP46 cDNA were generated by PCR and standard cloning techniques. For plasmid p42, which contains Bag-1\RAP46 cDNA nts 42-1164 (RAP46 cDNA co-ordinates ; [8] ), cDNA prepared from methyl mercury hydroxide-treated HaCaT poly(A) + RNA [a gift from Dr. P Farlie (Ludwig Institute for Cancer Research, St Mary's Branch, London, U.K.)] was amplified by PCR in the presence of 10 % (v\v) dimethyl sulphoxide using primers T6243 (CCCAAGCTTTGGGCGGTCAACAA-GTGCGG) and T6244 (CCGGGATCCAGAGACGGCAGA-GCTGGTGG). For plasmid p276, which contains Bag-1\RAP46 cDNA nts 276-1111, cDNA prepared from X50-7 total RNA was amplified by PCR using primers T0458 (CCCA-AGCTTGCGATGAAGAAGAAAACCCGGCG) and T0459 (CCGGATCCTGCTACACCTCACTCGGCCAG). The PCR products were digested with BamHI and HindIII and cloned into pBluescript KS(k) (Stratagene) digested with the same enzymes. For plasmid p406 (nts 406-1164), p42 was used in a PCR reaction with primers V1432 (CCCAAGCTTGAGATGAAT-CGGAGCCAGGAGG) and T6244 and the PCR product was digested with BamHI and HindIII and cloned into KS(k). For plasmid p289 (nts 289-1164), p42 was digested with FokI, treated with Klenow polymerase and then digested with BamHI and the cDNA sequences cloned into KS(k) was digested with EcoRV and BamHI. For plasmid p445 (nts 445-1164), p42 was digested with SalI and BamHI, and the cDNA sequences cloned into KS(k) were digested with the same enzymes.
Two point mutants were generated to disrupt translation initiation at the CTG codon at Bag-1\RAP46 cDNA nt 64 (C1) and the ATG codon at nt 409 (A2). In plasmid p42m, a stop codon was introduced immediately downstream of C1 in p42 by amplification of p42 using primers V3060 (CCCAAGCT-TTGGGCGGTCAACAAGTGCGGGCCTGGCTTAGC) and T6244. In plasmid p406m, the ATG codon was altered to GTG by amplification of p42 using primer V2398 (CCCAAGCTTG-AGGTGAATCGGAGCCAGGAGG) and T6244. In each case, the PCR products were digested with HindIII and BamHI and cloned into KS(k) digested with the same enzymes. The sequence of the 5h ends of all mutants was confirmed by double-stranded DNA sequencing.
In itro translations were performed using the TnT-coupled reticulocyte lysate system (Promega) in the presence of [$&S]-methionine, according to the manufacturer's instructions. After 1 h at 30 mC, reactions were diluted with 4 vol. of 1iprotein sample buffer and heated at 95 mC for 5 min before analysis by SDS\PAGE and fluorography. For each construct, translations were performed with multiple, individual clones and these gave identical results.
Subcellular fractionation
M1 cells were washed twice with PBS and then resuspended in lysis buffer [0.2 M sucrose, 50 mM Tris\HCl (pH 7.5), 1 mM EDTA, 0.1 mM DTT, 5 mM MgCl # and protease inhibitors] and disrupted by three cycles of freeze-thawing. The lysate was centifuged at 600 g at 4 mC for 10 min and the pellet was recovered as the nuclear fraction. The supernatant was then centrifuged at 10 000 g at 4 mC for 30 min in a microfuge and the pellet was recovered as the heavy membrane fraction. Finally, the resultant supernatant was centrifuged at 100 000 g at 4 mC for 60 min using an Optima TLX ultracentrifuge (Beckman) and the pellet was recovered as the light membrane fraction ; the final supernatant was the cytosol. The pellets were washed with lysis buffer and then resuspended in lysis buffer equivalent to the volume of the cytosolic fraction. For the total extract, an equal number of unfractionated M1 cells were also resuspended in a volume of lysis buffer equivalent to the volume of the cytosolic fraction. Equivalent volumes of the fractions and total cell extract were diluted with an equal volume of 2iprotein sample buffer and heated at 95 mC for 5 min. The total and nuclear fractions were sonicated briefly to shear genomic DNA and the samples were analysed by Western blotting.
RESULTS
Mammalian cells express two Bag-1 isoforms
To analyse Bag-1 expression, we performed immunoblot analysis of lysates prepared from mouse NIH3T3 fibroblasts and M1 myeloid cells and the human lymphoblastoid cell line, X50-7, using two Bag-1-specific antibodies. Anti-Bag-1 is a polyclonal antibody raised against a chimaeric protein containing the mouse Bag-1 protein fused to the C-terminus of GST. C-16 recognizes an epitope within amino acid residues 204-219 of mouse Bag-1. This sequence is well conserved in human Bag-1 sequences [7] . The major Bag-1 proteins in human and mouse cells migrated with apparent molecular masses of approximately 36 and 32 kDa respectively, similar to the 34 kDa and 29 kDa molecular masses previously reported (Figure 1 in [7] ). Anti-Bag-1 detected Bag-1 expression only in mouse cells and is therefore specific for murine Bag-1 proteins ( Figure 1A) . Importantly, both antibodies also detected a 50 kDa reactive protein in mouse cells and C-16 detected a 50 kDa protein in human cells. Since anti-Bag-1 and C-16 detect distinct epitopes, the p50 protein in human and mouse cells is closely related to the previously recognized Bag-1 proteins, and p50 is a novel Bag-1 isoform. We will refer to the prototypical Bag-1 proteins in murine and human cells as p32 and p36 Bag-1 respectively, and the novel isoform as p50 Bag-1. Anti-Bag-1 also detected a 35 kDa reactive protein in NIH3T3 fibroblasts, but this was not detected in other murine cell lines (Figure 2A and results not shown) and is likely to be due to crossreaction, since this protein was not detected by C-16. 
Bag-1 RNA and protein expression in murine haematopoietic cell lines
To further characterize expression of Bag-1 isoforms, we used the anti-Bag-1 antibody to analyse murine haematopoietic cell lines. p32 Bag-1 was detected in all cell lines examined and levels were relatively constant ( Figure 2A ). In contrast, levels of p50 Bag-1 were more variable. p50 Bag-1 was highly expressed in some lines (WEHI-3, WEHI-22), at levels approximately equivalent to p32, whereas in other lines p32 was more abundant than p50. Finally, one cell line (NFS-56) had little or no detectable p50 expression (results not shown). The variable expression of p50 Bag-1 was not related to any particular cell lineage. We next analysed Bag-1 RNA expression in these cell lines by Northern blotting using the mouse Bag-1 cDNA as a probe. A single major RNA was detected in all cell lines analysed, although some less abundant larger transcripts were also detected ( Figure  2B ). The modest variation in p32 Bag-1 expression, and the more significant variation in p50 Bag-1 expression, was not reflected in differences in Bag-1 RNAs, and regulation of Bag-1 protein expression is therefore due to post-transcriptional mechanisms, at least in some cells. Notably, the major Bag-1 RNA was approximately 1.4 kb, significantly larger than the published mouse Bag-1 cDNA [3] .
Analysis of mouse Bag-1 RNA structure
The sequence of the human Bag-1 cDNA has been reported recently [7] . This is very similar to the previously reported RAP46 cDNA [8] . Both cDNAs are approximately 1.3 kb and the
Figure 4 Human and mouse Bag-1 sequences
The alignment shows the hypothetical translations of the human Bag-1/RAP46 cDNA [7, 8] and the mouse Bag-1 cDNA [3] . Identities are indicated by vertical marks and similarities by dots. The position of the potential translation initiation sites in the 5h 500 bp of the human cDNA are boxed and termed C1-C4 and A1-A3 for in-frame CTG and ATG codons respectively. The first in-frame ATG (A1) has been proposed as the translation start site for the human p36 Bag-1 protein and the 46 kDa RAP46 protein [7, 8] . However, our analysis demonstrated that p50 Bag-1 translation initiates at codon C1 and p36 Bag-1 translation initiates at codon A2. few nucleotide differences between them (15, of which 8 alter the protein sequence) are likely to be due to sequencing errors. In contrast, the mouse Bag-1 cDNA is approximately 900 bp [3] , significantly shorter than the human Bag-1\RAP46 cDNA and the endogenous Bag-1 RNA in murine cells ( Figure 2B ). Primer extension analyses demonstrated that the cDNA lacks 5h sequences (results not shown), and we therefore attempted to clone and sequence additional mouse Bag-1 cDNA sequences. Using 5h RACE, we obtained 203 bp of a novel sequence upstream of the 5h end of the published mouse Bag-1 cDNA. To confirm the structure of the 5h part of the Bag-1 RNA in cells, we performed an RPA using the longest RACE clone as a probe. Full-length protection of the probe was evident, and therefore the cDNA sequences we have cloned are contiguous with the published cDNA and represent the major Bag-1 RNA in cells (Figure 3) . Moreover, the start of the published Bag-1 cDNA does not represent a major RNA start in mouse liver, as we did not detect a protected fragment consistent with an RNA with this structure (results not shown) ; therefore the published mouse Bag-1 cDNA [3] is a partial clone. Although we have cloned additional 5h Bag-1 RNA sequences, Northern blot and primerextension analyses suggested that the we still have not identified the extreme 5h end of the murine Bag-1 RNA. However, attempts to clone additional 5h sequences have failed, perhaps due to secondary structure in this part of the RNA.
We compared the hypothetical translations of the entire mouse and human RAP46\Bag-1 cDNAs, including the sequence obtained from RACE ( Figure 4) . The first in-frame methionine in each sequence (termed A1 in the human sequence) has been proposed as the translation start site for mouse Bag-1 [3] and the 36 kDa human Bag-1 [7] and 46 kDa RAP46 [8] proteins. Suprisingly, identity between mouse and human sequences was also apparent upstream of the presumed initiating methionines, suggesing that these sequences are coding. Although this region of the human Bag-1\RAP46 cDNA does not contain an in-frame ATG codon, it does contain three in-frame potential alternative CTG translation start codons (termed C1, C2 and C3 ; Figure 4) . Although CUG-initiated translation is relatively rare, CUGinitiated forms of, for example, c-Myc, Int2 and Hck proteins have been described [13] [14] [15] . Thus, the human Bag-1\RAP46 cDNA potentially contains extended ORFs which begin at CTG codons upstream of the first in-frame methionine proposed as the translation-initiation codon for p36 Bag-1 and RAP46 [7, 8] . An extended ORF may also be present in the murine Bag-1 RNA, as upstream sequences are also conserved with those present in the human.
Identification of human Bag-1 isoform translation start sites
There is considerable confusion in the literature concerning the structure of the products of the RAP46\Bag-1 cDNA and their relationship to the proteins expressed in cells. For example, the product of the ORF starting at the first in-frame methionine has been described as a 46 kDa (RAP46) or a 36 kDa (Bag-1) protein [7, 8] . Moreover, our analysis suggested that Bag-1 cDNAs may contain longer ORFs than originally suspected. To resolve these issues we therefore determined which of the ORFs in the human Bag-1 cDNA gave rise to the p50 and p36 Bag-1 proteins in human cells. Portions of the human Bag-1\RAP46 cDNA were subcloned ( Figure 5A ) and these constructs were used to programme coupled transcription-translation reactions (TnT lysates) in the presence of [$&S]methionine ; the protein products were analysed by autoradiography. The radioactive proteins were also compared with Bag-1 proteins in human cell lines detected using the C-16 antibody.
Translation of the largest Bag-1\RAP46 plasmid (p42, nts 42-1111) generated two proteins which comigrated with p50 Bag-1 and p36 Bag-1 expressed in human cells ( Figure 5B) . No proteins the size of RAP46 were detected in cell lysates, nor following translation of the full-length cDNA. In contrast, when sequences upstream of the first in-frame methionine were deleted in plasmid 276 (nts 276-1111), two major proteins of 46 and 36 kDa were generated. The size of the largest protein was consistent with that expected for RAP46, but a protein of this size was not detected in cells ( Figure 5B ). In contrast, the faster-migrating protein comigrated with p36 Bag-1 detected in human cells by immunoblotting ( Figure 5B) . Therefore, the Bag-1\RAP46 cDNA encodes both of the Bag-1 isoforms, and sequences upstream of the first in-frame methionine are required for p50 Bag-1 translation. The faster-migrating proteins observed in these translations do not correspond to any Bag-1 proteins in cells, and are presumably due to artefactual internal intitiation. Introduction of a stop codon immediately downstream of codon C1 in plasmid 42m completely abolished translation of p50 Bag-1 but not p36 Bag-1 ( Figure 5B ). Therefore p50 Bag-1 translation initiates 5h of the mutated codon, and since codon C1 is the only potential translation-initiation codon upstream of the introduced stop codon, p50 Bag-1 translation initiates at codon C1.
Since plasmids 42 and 276 directed translation of p36 Bag-1 in itro ( Figure 5B ), p36 Bag-1 translation initiates downstream of codon A1. Three in-frame potential translation-inititation codons are downstream of A1, termed C4, A2 and A3 (Figure 4 and 5B). We therefore generated additional plasmids to determine which codon was used to initiate translation of p36 Bag-1. In lysates programmed with plasmids 289 and 406, which sequentially delete initiation codons A1 and C4 (Figure 5A) , translation of
Figure 6 Distinct subcellular localizations of Bag-1 isoforms in M1 cells
M1 cells were fractionated by differential centrifugation and the resultant nuclear, heavy membrane (P10), light membrane (P100) and cytosolic fractions (S100) and a total cell extract derived from an equal number of cells were analysed by Western blotting using anti-Bag-1 (top panel) or anti-mouse Bcl-2 (bottom panel). The positions of migration of Bag-1 proteins and Bcl-2 are indicated. Analysis of the same fractions using an F 1 -β-ATPase-specific antibody as a mitochondrial marker demonstrated that mitochondria were present in the nuclear fraction (results not shown).
the 46 kDa protein, but not p36 Bag-1, was abolished ( Figure  5C ). In contrast, when codon A2 was deleted in plasmid 445, p36 Bag-1 translation was abolished. Finally, mutation of codon A2 abolished p36 Bag-1 translation ( Figure 5C ). Therefore, p36 Bag-1 translation initiates at codon A2.
Bag-1 isoforms have distinct subcellular localizations in M1 cells
The 32 kDa Bag-1 isoform interacts with Bcl-2 [3] , and since Bcl-2 associates with nuclear, mitochondrial and endoplasmic reticulum membranes [16] [17] [18] [19] we determined the subcellular localization of Bag-1 isoforms in M1 murine myeloid cells fractionated by differential centrifugation. Immunoblot analysis of these fractions using anti-Bag-1 demonstrated that p32 and p50 Bag-1 have distinct subcellular localizations. p32 Bag-1 was detected almost exclusively in the cytosolic fraction (S100), whereas p50 Bag-1 was present in the nuclear fraction ( Figure 6 ). This ' nuclear ' fraction also contains mitochondria, as judged by detection of the mitochondrial marker F " -β-ATPase in this fraction by immunoblotting (results not shown). Bcl-2 was detected exclusively in this fraction, consistent with the presence of nuclei and mitochondria. Since p32 Bag-1 was detected predominantly in the cytosol, this precludes the possibility that the nuclear fraction was contaminated with significant numbers of undisrupted cells. Therefore, Bag-1 isoforms localize differently within M1 myeloid cells, and p50 Bag-1, but not p32 Bag-1, co-fractionates with Bcl-2.
Recent experiments, carried out after the initial submission of the manuscript, demonstrate that N-terminal sequences present in human p50 Bag-1, but not p36 Bag-1, are sufficient to confer nuclear localization upon green fluorescent protein in transiently transfected Saos2 cells. Therefore p50 is likely to be a nuclear isoform (G. Packham and M. Brimmell, unpublished work)
DISCUSSION
In this report we demonstrate that murine and human cells express two Bag-1 isoforms. p50 expression is variable and in some murine cell lines p50 Bag-1 is expressed at levels equivalent to p32. Notably, Bag-1 isoforms also have different subcellular localizations in at least some cells, suggesting that p50 Bag-1 may be a functionally distinct form of Bag-1.
There has been considerable confusion in the literature concerning the structure and identity of Bag-1 and RAP46 proteins and we have resolved this confusion. Firstly, it is now clear that human Bag-1 and RAP46 are indeed the same gene, suggesting that, in addition to Bcl-2, Raf-1 and HGF and PDGF receptors [3, 5, 6] , Bag-1 isoforms interact with activated steroid hormone receptors. Second, neither Bag-1 isoform is generated by translation initiation at the first in-frame methionine as previously proposed [7, 8] . Rather, p50 Bag-1 translation initiates at an upstream CUG codon and p36 Bag-1 translation initiates at a downstream AUG codon. Therefore the major Bag-1 proteins in cells do not have the structures previously suggested by studies of either human Bag-1 or RAP46 [7, 8] . Small amounts of the 46 kDa protein are detected in some cell lines that we have studied (results not shown), but we have never detected significant levels. Although sequences upstream of codon C1 lack an inframe translation-termination codon, and it is possible that the cloned Bag-1\RAP46 cDNAs do not represent the full extent of the RNA in cells, the cDNA contains all of the Bag-1 coding information, since the largest product of the cDNA comigrates with the largest protein, p50 Bag-1, expressed in human cells.
Our analysis of Bag-1 isoform translation initiation has important implications for the domain structure of each isoform ; the structures of the human Bag-1 proteins are shown diagramatically in Figure 7 . The ubiquitin homology domain (p50 Bag-1 amino acid residues 169-200) first identified in murine p32 Bag-1 [3] , is highly conserved in human Bag-1 proteins and, like the putative bipartite nuclear localization signal (NLS) identified in RAP46 [8] , is present in both Bag-1 isoforms. However, in contrast to the ubiquitin-like domain, this putative bipartite NLS is not conserved in mouse Bag-1 proteins and therefore its significance is unclear. p32 Bag-1 is a soluble, cytoplasmic protein, whereas p50 Bag-1 is likely to be a nuclear protein. There are sequences in p50 Bag-1 similar to the simian virus 40 (SV40) large T NLS ( Figure 7C ), which, unlike the putative bipartite NLS [8] , are conserved in mouse p50 Bag-1. Since this motif is partly encoded by cDNA sequences upstream of the first in-frame methionine, this putative NLS has not previously been recognized in Bag-1\RAP46 proteins.
The murine p32 and human p36 Bag-1 proteins are approximately 80 % identical and 85 % similar, and the p50 Bag-1 sequences, known for both human and mouse are approximately 75 % identical and 80 % similar (Figure 4 ). The region of lowest identity is in the central portion of the p50 molecules. This region of human p50 Bag-1 contains ten copies of a repeat sequence rich in serine, threonine and acidic amino acid residues ( Figure 7B ), which is predicted to adopt a largely helical secondary structure. p36 Bag-1 translation initiates towards the end of this region and contains only four copies of the repeat. Significantly, the equivalent portion of the mouse p50 Bag-1 protein contains 11 copies of a very similar repeat rich in serine, threonine and charged amino acid residues. Thus, although primary sequence similarity is modest, these parts of murine and human Bag-1 proteins may be functionally equivalent. Analysis of protein databases failed to reveal significant sequence similarity of this repeat with other proteins, although it is interesting that a steroid hormone receptor coactivator, SRC-1, also contains a region rich in serine and threonine amino acid residues [20] .
Although relatively rare, translation initiation at CUG codons has been described for several proteins, including Hck, Int2 and c-Myc. Interestingly, similar to Bag-1 proteins, CUG-and AUGinitiated isoforms of Hck and Int2 are differently localized in cells [14, 15] , and the selection of translation-initiation codon may be used to control localization, and possibly activity, of Bag-1 proteins. In itro, translation of p50 Bag-1 is inefficient, and deletion of the 5h part of the cDNA greatly increases translation efficiency of the downstream ORFs. This is not due to a simple block in translation of the upstream ORFs, as blocking translation from codon C1 by introduction of a stop codon does not increase translation initiation at the downstream codons. Therefore, secondary structure in the 5h end of the Bag-1 RNA may prevent efficient translation of p50 Bag-1. This region has the potential to form stable stem-loop structures, and it is possible that regulation of Bag-1 RNA structure also influences translation in cells.
Since RAP46 and human Bag-1 are the same gene, our results suggest that, in addition to interacting with Bcl-2, Raf-1 and HGF and PDGF receptors, Bag-1 isoforms bind activated steroid hormone receptors and may play a role in regulating hormonedependent transcription as well as apoptosis. The in itro binding between RAP46 and the oestrogen receptor is stable in 1 M urea [8] , suggesting that binding to steroid hormone receptors is a high-affinity interaction and physiologically relevant. We are currently determining the activity of Bag-1 isoforms in regulating apoptosis and steroid hormone-dependent transcription, and whether Bag-1 proteins function independently, synergistically or antagonistically. In some cells, regulation of apoptosis and steroid hormone-dependent transcription are intimately linked (for example, dexamethasone-induced thymocyte apoptosis [21] ), and Bag-1 proteins may be a direct functional link between these pathways.
